BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26666815)

  • 1. Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.
    Polanska H; Heger Z; Gumulec J; Raudenska M; Svobodova M; Balvan J; Fojtu M; Binkova H; Horakova Z; Kostrica R; Adam V; Kizek R; Masarik M
    Tumour Biol; 2016 Jun; 37(6):7193-201. PubMed ID: 26666815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma.
    Ma X; Sheng S; Wu J; Jiang Y; Gao X; Cen X; Wu J; Wang S; Tang Y; Tang Y; Liang X
    Oncotarget; 2017 Jun; 8(26):42061-42075. PubMed ID: 28159935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
    Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
    Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
    Lajer CB; Garnæs E; Friis-Hansen L; Norrild B; Therkildsen MH; Glud M; Rossing M; Lajer H; Svane D; Skotte L; Specht L; Buchwald C; Nielsen FC
    Br J Cancer; 2012 Apr; 106(9):1526-34. PubMed ID: 22472886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
    Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
    Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.
    Shaikh MH; Khan AI; Sadat A; Chowdhury AH; Jinnah SA; Gopalan V; Lam AK; Clarke DTW; McMillan NAJ; Johnson NW
    BMC Cancer; 2017 Nov; 17(1):792. PubMed ID: 29178862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
    Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
    Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
    Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
    Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.
    Rautava J; Kuuskoski J; Syrjänen K; Grenman R; Syrjänen S
    J Clin Virol; 2012 Feb; 53(2):116-20. PubMed ID: 22177275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the tumour-adjacent tissue in head and neck cancers.
    Raudenska M; Sztalmachova M; Gumulec J; Fojtu M; Polanska H; Balvan J; Feith M; Binkova H; Horakova Z; Kostrica R; Kizek R; Masarik M
    Tumour Biol; 2015 Dec; 36(12):9929-39. PubMed ID: 26168959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
    Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
    Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer.
    Um SH; Mundi N; Yoo J; Palma DA; Fung K; MacNeil D; Wehrli B; Mymryk JS; Barrett JW; Nichols AC
    J Clin Virol; 2014 Sep; 61(1):94-100. PubMed ID: 25027574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus and head and neck squamous cell carcinomas in the South-East of France: prevalence, viral expression, and prognostic implications.
    Gavid M; Pillet S; Pozzetto B; Oriol M; Dumollard JM; Timoshenko AP; Martin C; Prades JM
    Acta Otolaryngol; 2013 May; 133(5):538-43. PubMed ID: 23350597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
    Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
    Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas.
    van Houten VM; Snijders PJ; van den Brekel MW; Kummer JA; Meijer CJ; van Leeuwen B; Denkers F; Smeele LE; Snow GB; Brakenhoff RH
    Int J Cancer; 2001 Jul; 93(2):232-5. PubMed ID: 11410871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
    Du S; Liu K; Gao P; Li Z; Zheng J
    Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.